Glido MP1 Tablet ER
Glido MP1 Tablet ER
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Glido MP1 Tablet ER is a combination oral antidiabetic medication containing Glimepiride (1mg), Metformin (500mg), and Pioglitazone (15mg), formulated for extended release to improve glycemic control in patients with type 2 diabetes mellitus. Glimepiride, a sulfonylurea, stimulates pancreatic beta cells to enhance insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production and improving peripheral insulin sensitivity, contributing to better glucose uptake and utilization. Pioglitazone, a thiazolidinedione, further enhances insulin sensitivity in adipose tissue, muscle, and the liver by activating peroxisome proliferator-activated receptor gamma (PPAR-γ). The combination targets multiple pathophysiological defects of type 2 diabetes, providing a complementary mechanism of action to achieve optimal glycemic control. Glido MP1 Tablet ER is indicated as an adjunct to diet and exercise for patients inadequately controlled on monotherapy or dual therapy. Extended-release formulation allows for once-daily dosing, improving patient compliance. Caution is advised in patients with renal or hepatic impairment, heart failure, or a history of lactic acidosis. Regular monitoring of blood glucose, renal function, and liver enzymes is recommended. Adverse effects may include hypoglycemia, gastrointestinal disturbances, weight gain, and edema. This medication should be used under medical supervision with appropriate lifestyle modifications.
Active composition
Glimepiride 1 mg
+2 more active ingredients
About Glimepiride
Glimepiride is an oral hypoglycemic agent used to manage blood sugar levels in patients with type 2 diabetes mellitus. It works by stimulating the pancreas to release more insulin, thereby lowering blood glucose levels and preventing the symptoms associated with diabetes. Glimepiride is often prescribed alongside diet and exercise to enhance glycemic control and reduce the risk of diabetes-related complications, such as kidney damage and neuropathy. In summary, Glimepiride is an essential medication for controlling blood sugar levels in type 2 diabetes patients.
How It Works
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
All Active Ingredients
Pioglitazone
Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.
Metformin
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glido MP1 Tablet ER.
High Risk
Pregnancy
Glido MP1 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glido MP1 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glido MP1 Tablet ER may be needed. Please consult your doctor. Use of Glido MP1 Tablet ER is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glido MP1 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glido MP1 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glido MP1 Tablet ER may be needed. Please consult your doctor. Use of Glido MP1 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Regular Checkup
Customer Reviews
0 reviews for Glido MP1 Tablet ER
